Ptc Therapeutics Inc (PTCT)

EBITDA Margin

44.91%

Quarterly · Period ending:

PTCT logo

PTCT EBITDA Margin

Latest reported44.91%
PTCT Quarterly EBITDA Margin (-50.90% → 44.91%)
High-resolution chart · PNG

PTCT ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Ptc Therapeutics Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
44.9075%
22.7411%
-43.1105%
9.7755%
-18.5107%
82.5733%
-21.9893%
-25.3555%
-18.8668%
5.4888%
-10.4447%
-38.8527%
-73.458%
-29.4189%
-75.4593%
-33.0917%
-58.9267%
-48.4506%
-58.8849%
-68.5498%
-68.8548%
-80.9254%
-21.0543%
-12.4337%
-220.3033%
-142.9672%
-52.9831%
-69.357%
-36.5286%
-116.0629%
-22.0378%
-75.4287%
0.9412%
-19.1235%
14.5957%
-49.2127%
-24.313%
-96.9714%
-93.2595%
-135.9567%
-228.6509%
-198.9574%
-372.2632%
-424.3094%
-595.8072%
-692.3802%
-273.1253%
-3,394.9812%
-1,749.4358%
-148.945%
-445.4053%
-23.8558%
-236.136%
-130.9421%
-90.8833%
-105.7117%
-83.2951%
-50.8961%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.